| Hematopoietic stem cell transplantation K Khaddour, CK Hana, P Mewawalla | 172 | 2019 |
| Tumor necrosis factor inhibitors V Gerriets, A Goyal, K Khaddour | 108 | 2018 |
| Thrombotic thrombocytopenic purpura evaluation and management JAN Zuno, K Khaddour StatPearls [Internet], 2023 | 64 | 2023 |
| The landscape of novel therapeutics and challenges in glioblastoma multiforme: contemporary state and future directions K Khaddour, TM Johanns, G Ansstas Pharmaceuticals 13 (11), 389, 2020 | 54 | 2020 |
| Signaling pathways and therapeutic approaches in glioblastoma multiforme M Khabibov, A Garifullin, Y Boumber, K Khaddour, M Fernandez, ... International journal of oncology 60 (6), 1-18, 2022 | 45 | 2022 |
| Case report: the importance of novel coronavirus disease (COVID-19) and coinfection with other respiratory pathogens in the current pandemic K Khaddour, A Sikora, N Tahir, D Nepomuceno, T Huang The American Journal of Tropical Medicine and Hygiene 102 (6), 1208, 2020 | 40 | 2020 |
| Targeting the epidermal growth factor receptor in EGFR-mutated lung cancer: current and emerging therapies K Khaddour, S Jonna, A Deneka, JD Patel, ME Abazeed, E Golemis, ... Cancers 13 (13), 3164, 2021 | 37 | 2021 |
| Acral vascular necrosis associated with immune-check point inhibitors: case report with literature review K Khaddour, V Singh, M Shayuk BMC cancer 19, 1-6, 2019 | 31 | 2019 |
| Tumor necrosis factor (TNF) inhibitors V Gerriets, P Bansal, K Khaddour StatPearls. Treasure Island (FL): StatPearls Publishing, 2020 | 28 | 2020 |
| Trastuzumab K Greenblatt, K Khaddour | 26 | 2018 |
| Pituitary carcinoma: two case reports and review of literature L Xu, K Khaddour, J Chen, KM Rich, RJ Perrin, JL Campian World Journal of Clinical Oncology 11 (2), 91, 2020 | 25 | 2020 |
| Induced remission of metastatic squamous cell carcinoma with an immune checkpoint inhibitor in a patient with recessive dystrophic epidermolysis bullosa K Khaddour, ES Gorell, F Dehdashti, JY Tang, G Ansstas Case Reports in Oncology 13 (2), 911-915, 2020 | 23 | 2020 |
| Obesity, sarcopenia, and outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors K Khaddour, SL Gomez-Perez, N Jain, JD Patel, Y Boumber Frontiers in Oncology 10, 576314, 2020 | 22 | 2020 |
| Thrombotic thrombocytopenic purpura evaluation and management JA Nuñez Zuno, K Khaddour StatPearls. Treasure Island (FL): StatPearls Publishing, 2020 | 22 | 2020 |
| Successful use of BRAF/MEK inhibitors as a neoadjuvant approach in the definitive treatment of papillary craniopharyngioma K Khaddour, MR Chicoine, J Huang, S Dahiya, G Ansstas Journal of the National Comprehensive Cancer Network 18 (12), 1590-1595, 2020 | 20 | 2020 |
| Characteristics of clear cell renal cell carcinoma metastases to the thyroid gland: A systematic review K Khaddour, N Marernych, WL Ward, J Liu, T Pappa World Journal of Clinical Cases 7 (21), 3474, 2019 | 20 | 2019 |
| Tumor Necrosis Factor Inhibitors. StatPearls V Gerriets, P Bansal, A Goyal, K Khaddour StatPearls Publishing, 2020 | 19 | 2020 |
| Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches K Khaddour, L Maahs, AM Avila-Rodriguez, Y Maamar, S Samaan, ... Cancers 13 (22), 5847, 2021 | 17 | 2021 |
| Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer? PB Santos, H Patel, R Henrique, A Félix World journal of clinical oncology 11 (2), 43, 2020 | 15 | 2020 |
| Telangiectatic osteosarcoma F Limaiem, J Kuhn, V Tiwari, K Khaddour | 14* | 2019 |
